The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

The recent trial regarding the discontinued heartburn drug Zantac, which allegedly causes cancer, ended in a hung jury. The ...

Zantac -- also known as ranitidine -- was a popular heartburn ... But both cases have ended with a hung jury, the most recent one yesterday. The jurors were unable to decide whether German ...

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

A Chicago jury failed to reach a verdict in the latest Zantac cancer trial involving Boehringer Ingelheim. Plaintiff Ronald ...

Recent surprise decisions have upended plaintiffs’ expectations on the toxic tort front. In Delaware, the top court is ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

GSK has opted to settle a key lawsuit in its defence against claims that its Zantac drug caused cancer, rather than proceed with a jury trial. The company said this morning it had reached a ...

Three Zantac cases so far have gone to trial, with two ending in verdicts for the defense and one with a hung jury.

A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported.

Three Zantac cases so far have gone to trial, with two ending in verdicts for the defense and one with a hung jury.

Delaware's highest court said on Tuesday it will hear an appeal by GSK GSK.L and other drug makers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused ...